icon

The sensational surge in share price continues for Implant Sciences (IMSC). Shares broke through the $1.50 barrier on Thursday after a flow of solid news over the past couple of weeks ignited a run that started out at well below a dollar. In fact, those looking back just a few months will realize that IMSC has well more than doubled during that time frame...

Read more

Shares of Lpath, Inc. (LPTN) were cruising along earlier this year at prices over the dollar mark and supported by volume fluid enough to sustain those levels. Investors were keyed into this small company's status as a recognized leader in the field of lipid-based therapeutics and were also quick to notice the interest of Pfizer, Inc (PFE), which jumped on board early on in development when it became apparent that Lpath was, at least to date, the only company to have successfully developed monoclonal antibodies against bioactive lipids...

Read more

Although shares of Prolor Biotech (PBTH) have dipped below the five dollar mark during the month of June, they jumped again by five percent on Tuesday after the company released news that it had re-presented data from an already-completed Phase II trial for hGH-CTP at ENDO 2012, the 94th Annual Meeting and Expo of the Endocrine Society.

The event was held in Houston, Texas from June 23-26, and provided Prolor with another grand stage to circulate the potential of hGH-CTP as a once-weekly injection for hormone-deficient adults, replacing the current standard of care that includes daily injections, seven days per week...

Read more

Last week was a pivotal one for Implant Sciences (IMSC), as a slew of impressive new hires validated the fact that the company's Quantum Sniffer (QS) explosive trace detection (ETD) technology may be on the verge of receiving a key qualification approval form the U.S. Transportation Security Administration (TSA) that would vault Implant to the forefront of the homeland security industry.

Investors considered the impact that such an approval from the TSA would have on the small and lightly-traded Implant Sciences and started buying shares in droves, which also might have compelled the shorts - which were slowly increasing their positions as well - to start covering...

Read more

At the conclusion of each week,VFC's Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well.

Last week was one full of elections, and as a result, new governments are now sitting in key positions around the globe, most notably in Greece, France and Egypt. The elections in Greece that were eyed so heavily leading into last weekend failed to impact the global stock markets much since it was generally believed that the newly-elected government of the New Democracy party, headed by Antonis Samaras, would favor the already-imposed measures of austerity that would position the country to remain within the Euro Zone (EZ)...

Read more

Already a hot item over the past couple of weeks - thanks to some releases of essential information that are solid indicators that Implant Sciences (IMSC) is ready to take its game to the next level - Implant is certainly an even hotter item on Wednesday as shares traded up by seven percent on volume that approached 400,000 - all before the clock ticked 11 AM...

Read more

Implant Sciences (IMSC), a company with game-changing technology that is quickly gaining traction in the explosives trace detection (ETD) industry, announced another major move on Monday that brings with it another layer of validation and foretells the probability that the company is ready to make a major move into the arena of defending the United States homeland...

Read more

At the conclusion of each week,VFC's Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well.

The positive market action seen during the week of June 4 continued last week as well and the DOW posted another gain of 300-plus points, including a rise of 115 points on Friday that set a positive tone through the markets heading into Sunday's Greek elections. Undoubtedly, the results of those elections will shape the trading action during the upcoming week, too...

Read more

Earlier this week it was noted that shares of NovaBay Pharmaceuticals (NBY) - a potential bargain that the market may not be adequately valuing  - had started to move higher following a recent trip to below the dollar mark.  That move continued on Wednesday as an eight percent jump resulted in a close of just under a buck-thirty, a level not reached seen in over a month...

Read more

Keep an eye on shares of Capstone Turbine (CPST) on Thursday.  The company is set to report with analysts predictin, on average, a loss of two cents per share, better numbers than during the same period of last year, but still under the ultimate goal of profitability, which has thus far eluded this company.

More important than the actual losses, however, will be the recognized trend.  Investors will want more evidence of improved margins and realized progress in moving heftily through the backlog that has been growing in size and scope, thanks to some large orders over the past few quarters...

Read more

Late last year shares of Siga Technologies (SIGA) started taking a dive as news of a lawsuit filed by rival PharmAthene (PIP) circulated the wires.  Having traded for over ten dollars for some time, shares quickly found a home at below four bucks when a judge essentially ruled in favor of PharmAthene and awarded the company 50% of Siga's profits for the smallpox antiviral ST-246, for which Siga landed a huge contract from the Biomedical Advanced Research and Development Authority of the United States Department of Health and Human Services (BARDA) last year. ..

Read more

A solid day of trading for NovaBay Pharmaceuticals (NBY) on Tuesday placed the share price back at the $1.20 mark, barely two weeks after the stock was hitting intra-day lows of ninety cents.  A modest mid-week runup that began last week fueled the move to the one-twenty mark, a significant move in terms of percentages.

Volume of more than double the daily average drove the most recent leg of the runup, an encouraging sign that investors may still be taking notice of the fact that the potential of NovaBay's technology may not be accurately portrayed by the current share price and market cap...

Read more

Teletouch Commications (TLLE) has been making a play as a growth story of late, following the settled resolution of litigation with AT&T (T) that filled the cash coffers with a few bucks, and that trend continued this week as the company announced that Cellphone-Mate, Inc., a leading designer and manufacturer of high quality wireless signal amplifiers and repeater systems, has signed a multi-year contract with Teletouch subsidiar, Progressive Concepts, Inc. dba PCI Wholesale, who will now become an exclusive "Master Distributor" of Cellphone-Mate products...

Read more

A key catalyst that is just months away could launch Implant Sciences (IMSC) into the mainstream of homeland defense and global security. The Transportation Security Administration (TSA) is currently reviewing Implant's explosives and narcotics trace detection technology for approval for use in the United States and a potential positive approval ruling would not only provide a key catalyst for the IMSC share price, but it would open the doors for Implant to quickly become a global leader in providing airport and air cargo security, among other security-related services...

Read more

Volume has been steadily on the rise for shares of Synergy Pharmaceuticals (SGYP), and as a result, the share price has been inching higher as well. SGYP closed Monday having traded just about double the daily norm after a mid-day volume spike that led to a closing price a couple of percentage points higher than the open. The strong-volumed trend continued into Tuesday's trading, another day where SGYP shares registered a gain of a few percentage points....

Read more

The Ampio Pharmaceuticals (AMPE) pipeline is still trucking along.

Shares were up by over ten percent during the pre-market hours on Monday after the company announced positive trial results for the orally-administered Optina in the treatment of diabetic macular edema (DME). The DME trial was conducted in Canada and based on the positive results Ampio has planned a pre-IND meeting with the US FDA as part of preparations to bring Optina through the approval process in the United States...

Read more

At the conclusion of each week,VFC's Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. Last week opened with a pure focus on the tumultuous dive experienced by the market during the previous trading week, but encouraging headlines and positive signs from Europe reversed the downfall and the stock market as a whole ended up enjoying its best week of the year.

The question for the upcoming trading week is...will the 'rebound run' continue?

...

Read more

Since deciding to focus on its core distribution business earlier this year, Teletouch Communications (TLLE) has announced a flurry of new deals that have potentially positioned the company to realize significant growth over the coming quarters. Just last month alone Teletouch's wholly-owned subsidiary, Progressive Concepts, Inc. dba PCI Wholesale, has landed multiple distribution agreements with key players in the industry, including Wilson Electronics, Parrot, Inc., Aerovoice, Inc., and PureGear, among others...

Read more

Shares of NovaBay Pharmaceuticals (NBY) looked like quite the attractive speculative buy just days ago when company shares saw the stock trade for right around ninety cents, but a rebound over the past couple of trading days on increased volume indicates that investors may still consider NovaBay as an undervalued growth story, based mainly on the potential of the company's potential blockbuster technology.

As the broad markets rebounded heavily on Wednesday as concerns eased of an economic catastrophe in Europe (funny how opinions change so remarkably from day to day), NBY also rebounded, opening the day significantly higher - in terms of percentages - than the previous day's close with volume that was roughly four times the daily norm barely a couple of hours into the trading day...

Read more

A modest up day for the DOW on Tuesday - although an encouraging sign that a protracted stock market decline might have been warded off, at least temporarily - did little to alleviate the fact that a lot of big money is leaving the market in a hurry, possibly as a result of fears eminating from Europe over a debt crisis, or even just because the big boys like to pull their money out of the market to enjoy some summer European holidays.

Either way, now is the time to be looking for steals and deals in the market, whether those deals have been created by this and last week's respective pullbacks, or whether there are other factors that have contributed to a particular company's share price decline that have positioned it for a potential rebound...

Read more

A few weeks ago Cytosorbents Corp (CTSO) rebounded quickly after a post-earnings drop, indicating continued investor confidence as the commercial roll-out in Germany got underway, but a down market has returned shares right back to the dime level. Consequently, the dime level has proven to provide investors of all types with opportunities to jump in and take up a position in the company, whether it be for a long term hold or short term trade.

This trip to ten cents may be no different.

After flat lining for a couple of weeks prior, volume picked up on Monday to open the new trading week, providing an indication that investors may yet again be ready to take advantage of a CTSO pullback...

Read more

As the market tumbled lower this past Friday, shares of Synergy Pharmaceuticals (SGYP) held strong and jumped by six percent. Shares jumped another two percent during after hours trading that day and then held strong through Monday's trading, even with the markets experiencing another down day.

Trading volume over the past few trading sessions has come in at well over twice the daily norm, indicating that big money may be starting to buy in, even at a time when money is flowing out of the market in droves due to concerns of another global economic meltdown that could threaten a thus-far solid recovery in the United States...

Read more

At the conclusion of each week,VFC's Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. This week is all about Friday's market drop and the prospects of a continued decline moving forward. Given the new bear market, we'll also take a look at some evolving deals, bargains and potential steals that may be taking shape with eyes towards an eventual rebound.

For the better part of the last six months the analysts, pundits and investors have all wondered if, or more aptly - when - the next market correction would take shape after seeing the DOW soar to levels approaching previously-established record highs during a nice period of rebound.  Most of the pullbacks experienced over the past few quarters were easily halted, only to be followed by another push higher, but all that changed last week when the DOW dropped by more than two percent on Friday to put an exclamation point on the end of a tumultuous week.

When the closing bell rang, all of the early-year gains were effectively erased and already-jittery investors were wondering what's next to come...

Read more